Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group Database.

Saved in:
Bibliographic Details
Title: Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group Database.
Authors: Kaedbey R; Department of Medicine, Jewish General Hospital, Montreal, Quebec, Canada. Electronic address: rayan.kaedbey@mcgill.ca., Venner CP; Department of Medicine, BC Cancer, Vancouver Centre, Vancouver, Canada., Reece D; Department of Medical Oncology and Hematology, Canadian Myeloma Research Group, Princess Margaret Cancer Centre, Toronto, Canada., Hay K; Department of Medicine, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Gul E; Canadian Myeloma Research Group, Vaughan, Ontario, Canada., Su J; Canadian Myeloma Research Group, Vaughan, Ontario, Canada., McCurdy A; Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada., Chu MP; Department of Medicine, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada., Jimenez-Zepeda VH; Department of Medicine, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Song K; Department of Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, Canada., Mian H; Department of Medicine, Juravinski Cancer Center, Hamilton, Ontario, Canada., Louzada M; Department of Medicine, London Regional Cancer Center, London, Ontario, Canada., Sebag M; Department of Medicine, McGill University, Montreal, Quebec, Canada., Reiman A; Department of Medicine, Saint John Regional Hospital, Saint John, New Brunswick, Canada., White D; Department of Medicine, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia, Canada., Stakiw J; Department of Medicine, Saskatoon Cancer Centre, University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Kotb R; Department of Medicine, Cancer Care Manitoba, Winnipeg, Manitoba, Canada., Aslam M; Department of Medicine, Allan Blair Cancer Centre, Regina, Saskatchewan, Canada., Masih-Khan E; Department of Medical Oncology and Hematology, Canadian Myeloma Research Group, Princess Margaret Cancer Centre, Toronto, Canada., Bergstrom D; Department of Medicine, Division of Hematology, Memorial University of Newfoundland, St John's, Newfoundland and Labrador, Canada., LeBlanc R; Department of Medicine, Maisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, Quebec, Canada.
Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2026 Mar; Vol. 26 (3), pp. e357-e366. Date of Electronic Publication: 2025 Oct 31.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2152-2669
DOI:10.1016/j.clml.2025.10.026